EVE HOLDING, INC. financials

EVEX CIK 0001823652

Source: EDGAR filings · Built 2026-06-02T02:56:38Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2022
Free Cash Flow -172.99M -141.18M -94.68M -59.93M -14.89M -9.03M
EBITDA -224.46M -156.12M -130.37M -189.47M -18.07M -9.59M
Working Capital 286.11M 253.46M 190.23M 287.27M 10.70M 1.93M
Net Debt 76.85M 76.69M -20.61M -48.93M
Return on Equity (ROE) -181.20% -111.50% -77.34% -60.65% -170.63% 949.30%
Return on Assets (ROA) -51.57% -43.42% -52.03% -55.62% -84.63% -4.10%
Current Ratio 3.29× 5.27× 4.66× 12.52× 2.05× 6.48×
Debt-to-Equity 1.46× 1.07× 0.16× 0.00×
Effective Tax Rate -0.45% -0.37% -1.24% -0.54% 0.00% 0.00%
Cash Conversion Ratio 0.72× 0.98× 0.74× 0.34× 0.82× 0.94×
Accruals Ratio -0.15× -0.01× -0.14× -0.37× -0.16× -0.00×
CapEx Coverage -12.78× -26.07× -562.55× -124.91×
Free Cash Flow Per Share $-0.54 $-0.49 $-0.34 $-0.24 $-0.07 $-0.04

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2022
P/B 11.23× 13.07× 11.95× 6.75×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2022
Research and Development Expense 194.69M 129.84M 105.58M 51.86M 13.28M 8.36M
Selling, General and Administrative Expense 30.69M 26.53M 23.10M 32.86M 4.90M 1.23M
Operating Expenses 225.39M 156.37M 130.55M 189.49M
Operating Income (Loss) -225.39M -156.37M -130.55M -189.49M -18.18M -9.59M
Income Tax Expense (Benefit) 1.01M 507.00K 1.57M 933.00K 0 0
Net Income (Loss) Attributable to Parent -224.25M -138.17M -127.66M -174.03M -18.26M -9.63M
Earnings Per Share, Basic $-0.70 $-0.48 $-0.46 $-0.68 $-0.08 $-0.04
Weighted Average Number of Shares Outstanding, Basic 321.35M 288.52M 275.76M 254.13M 220.00M 220.00M
Earnings Per Share, Diluted $-0.70 $-0.48 $-0.46 $-0.68 $-0.08 $-0.04
Weighted Average Number of Shares Outstanding, Diluted 321.35M 288.52M 275.76M 254.13M 220.00M 220.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2022
Cash and Cash Equivalents, at Carrying Value 103.23M 56.37M 46.88M 49.15M 14.38M 1.97M
Assets, Current 410.87M 312.81M 242.22M 312.21M 20.87M 2.28M
Assets 434.88M 318.24M 245.34M 312.88M 21.57M 234.58M
Long-term Debt 179.78M 132.01M 25.76M
Liabilities, Current 124.77M 59.34M 51.99M 24.93M 10.17M 352.05K
Long-term Debt, Excluding Current Maturities 176.41M 132.01M 25.76M 0
Liabilities 311.12M 194.32M 80.29M 25.95M 10.87M 48.46M
Stockholders' Equity Attributable to Parent 123.76M 123.92M 165.05M 286.92M 10.70M -1.01M
Common Stock, Shares, Outstanding 348.30M 297.64M 269.36M 269.09M 220.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2022
Net Cash Provided by (Used in) Operating Activities -160.43M -135.97M -94.51M -59.46M -14.89M -9.03M
Payments to Acquire Property, Plant, and Equipment 12.55M 5.22M 168.00K 476.00K 0 0
Net Cash Provided by (Used in) Investing Activities -46.73M -56.22M 66.83M -258.48M 0 0
Net Cash Provided by (Used in) Financing Activities 263.12M 203.02M 24.93M 352.70M 29.26M 9.03M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (EVEX CIK 0001823652), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ACTU

ACTUATE THERAPEUTICS, INC.

FIVE

Five Below, Inc.

PALI

PALISADE BIO, INC.